Xianju now has more than 10 dosage forms and an experienced R&D teams that can develop a variety of oral preparations, injections, external preparations and inhalants. Besides, furnished with more than 200 sets of R&D devices including fluidized beds, jet mills, particulate monitors, and freeze dryers, the platform is capable of offering the company various new products.